<DOC>
	<DOCNO>NCT01643148</DOCNO>
	<brief_summary>Objective : Evaluate body mass index ( BMI ) , leptin , Leptin/adiponectin ( L/A ) ratio cancer antigen ( CA ) 15-3 together reliable biomarkers breast cancer . Patients : Consecutive patient age 40 - 60 year , breast disease inform consent . Interventions : Patients ' Anthropometric laboratorial characteristic classify BMI group cancer patient benign breast disease well biochemical test leptin , adiponectin , CA 15-3 , hemoglobin , glucose low-density lipoprotein cholesterol ( LDLC ) , high-density lipoprotein cholesterol ( HDLC ) level obtain well blood sample analyze CA 15-3 level electrochemiluminescence immunoassay . Hypothesis : Using together leptin , L/A ratio , CA 15-3 BMI could offer reliable approach detect high risk woman develop breast cancer .</brief_summary>
	<brief_title>The Tetrad BMI , Leptin , Leptin/Adiponectin ( L/A ) Ratio CA-15-3 Reliable Biomarker Breast Cancer</brief_title>
	<detailed_description>Serum level leptin , adiponectin CA 15-3 , well anthropometric biochemical parameter analyze 88 female patient attend mammography study . Predictive value BMI , leptin , L/A ratio CA 15-3 determine 95 % confidence interval ( CI ) .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<criteria>Female patient attend mammography , average age fourth fifth decade . Patients hormonal therapy .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>biomarker</keyword>
	<keyword>BMI</keyword>
	<keyword>breast cancer</keyword>
	<keyword>CA-15-3</keyword>
	<keyword>leptin</keyword>
</DOC>